Patents by Inventor BRETT GOLDSMITH

BRETT GOLDSMITH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230333051
    Abstract: An apparatus may include a memory storing transfer curve information for the 2D FETs obtained by applying bias conditions including a drain-to-source voltage and a gate-to-source voltage to the 2D FETs, and measuring channel currents for the 2D FETs while varying the gate-to-source voltage of the 2D FETs. An apparatus may include a characterization parameter encoder that determines the one or more output characterization parameters as output data of a machine learning model by applying the transfer curve information for the 2D FETs as input data to the machine learning model, wherein the machine learning model has been trained to output the one or more output characterization parameters of the fit function for an input of the transfer curve information for the 2D FETs. A system and methods for training and using the machine learning model are disclosed.
    Type: Application
    Filed: May 17, 2023
    Publication date: October 19, 2023
    Inventors: Brett Goldsmith, Jonathan Parkinson, Kiana Aran, Alexander Kane
  • Publication number: 20230273150
    Abstract: Apparatuses, systems, and methods are disclosed for an integrated circuit with 2D field-effect transistors and on-chip thin film layer deposition with electrical characterization. A corresponding layer structure and manufacturing process are disclosed. The system includes a measurement controller that determines transfer curve information and an analysis module that generates parameters for determining thickness and/or porosity and a thin film deposition controller that controllers thin film deposition using the parameters. Methods include performing liquid mediated deposition of one or more thin film layers on the channel surface and obtaining transfer curve information by generating time dependent measurement vectors for the 2D FETs and controlling and/or performing electrical characterization of the of thin film layers based on the measurement vectors. The disclosed methods may be implemented by the disclosed integrated circuit and the disclosed system.
    Type: Application
    Filed: February 24, 2023
    Publication date: August 31, 2023
    Inventors: Kiana Aran, Brett Goldsmith, Jeffrey Taulbee
  • Patent number: 11713455
    Abstract: For enhanced selection of efficient targeted genome manipulating agents, an apparatus includes first and second chip-based biosensors having one or more sensing surfaces configured to detect biomolecular binding interactions between a nucleic acid sample and a targeted genome manipulating agent functionalized to a capture surface within a sensing range of the one or more sensing surfaces. The first chip-based biosensor uses a nucleic acid sample incubated with a blocking agent that blocks on-target binding and the second chip-based biosensor holds a nucleic acid sample that omits the blocking agent. A measurement apparatus measures first and second sets of response signals produced in response to the biomolecular binding interactions occurring between the nucleic acid sample and the targeted genome manipulating agent. An analysis module determines the genome manipulating efficiency parameters of the targeted genome manipulating agent. A system and a method perform the functions of the apparatus.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: August 1, 2023
    Assignee: Cardea Bio, Inc.
    Inventors: Regis Peytavi, Kiana Aran, Brett Goldsmith, Alexander Kane
  • Patent number: 11561197
    Abstract: Apparatuses, systems, and methods are disclosed for target detection based on collateral cleavage of a reporter by an enzyme. A biologically gated transistor may include a channel and a reporter moiety immobilized to the channel. The state of the reporter moiety may affect one or more output signals from the biologically gated transistor when excitation conditions are applied to the biologically gated transistor and a sample fluid is applied in contact with the channel. A sample fluid may include an enzyme configured to activate in response to a target nucleic acid to cleave the reporter moiety. Excitation circuitry may apply the excitation conditions, and measurement circuitry may measure output signals from the biologically gated transistor. An analysis module may determine a parameter relating to presence of the target nucleic acid, based on the one or more measurements.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: January 24, 2023
    Assignee: AMMR JOINT VENTURE
    Inventors: Kiana Aran, Alexander Kane, Brett Goldsmith, Regis Paytavi
  • Publication number: 20220365024
    Abstract: A system and apparatus for direct or indirect target substance signal measurement include an integrated circuit with an array of 2D FETs with corresponding 2D transistor channels and a gate area for receiving a volume of liquid with one or more chemical or biological target substances, a conductive source electrically coupled to a first end of the 2D transistor channel, a conductive drain electrically coupled to a second end of the 2D transistor channel, a ceramic coating over the conductive source and the conductive drain and a thin film layer of synthetic biopolymer specific binding agents is adsorbed to the top surface of the 2D transistor channel. Methods for the system and apparatus and for selecting the synthetic biopolymer specific binding agents based on absorptivity are disclosed.
    Type: Application
    Filed: May 20, 2022
    Publication date: November 17, 2022
    Inventors: Kiana Aran, Brett Goldsmith, Alexander Kane, Regis Paytavi
  • Patent number: 11215580
    Abstract: A DNA sequencing and blood chemistry analysis system and method are provided including one or more sensor chips and one or more sample wells, wherein each sample well is configured to form a seal with one of the sensors. The one or more sensor chips may comprise Graphene transistors, and each transistor having an associated sequencing probe. The sensor chips interact with a biological sample introduced into the sample well, wherein changes in the current, transconductance, and resistance of the Graphene transistors are indicative of a DNA binding process. Based on the associated sequencing probes, the DNA sequence present in a biological sample can be identified.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: January 4, 2022
    Assignee: Cardea Bio, Inc.
    Inventor: Brett Goldsmith
  • Publication number: 20210382046
    Abstract: Apparatuses, systems, and methods are disclosed for chemically differentiated sensor arrays and methods of manufacturing and using the same. In one or more examples. An integrated circuit chip includes a chemically differentiated array of graphene field effect transistors with one or more wells configured to receive a volume of biological sample liquid comprising a plurality of different types of biological substances to be distinguished using electrical measurements of output signals of the graphene field effect transistors. At least one electrode is configured to apply a changing gate bias voltage (VGs) that increases and decreases within a predetermined range to the sample liquid and at least one electrode is configured to monitor measurement vectors including slopes of drain current measurements relative to the voltage measurements and differences in slope of the measurement vectors distinguish different biological substances in the sample liquid. Systems and methods utilize the integrated circuit chip.
    Type: Application
    Filed: August 13, 2021
    Publication date: December 9, 2021
    Inventor: Brett Goldsmith
  • Publication number: 20210382045
    Abstract: Apparatuses, systems, and methods are disclosed for excitation and measurement of biochemical interactions. Excitation circuitry is configured to apply one or more excitation conditions to a biologically gated transistor that includes a channel, so that one or more output signals from the biologically gated transistor are affected by the excitation condition(s) and by a biochemical interaction of moieties within a sample fluid in contact with the channel surface. Measurement circuitry is configured to obtain information corresponding to the biochemical interaction occurring at one or more measurement distances greater than an electrostatic screening distance from the surface of the channel, by performing a plurality of time-dependent measurements of affected output signals, using a measurement bandwidth that corresponds to the measurement distances. An analysis module is configured to characterize one or more parameters of the biochemical interaction based on the time-dependent measurements.
    Type: Application
    Filed: June 8, 2021
    Publication date: December 9, 2021
    Inventors: Kiana Aran, Brett Goldsmith, Alexander Kane, Regis Peytavi
  • Patent number: 11092598
    Abstract: A chemically differentiated sensor array system includes a plurality of environmentally-gated transistors and an environmental gate, wherein the environmental gate includes a liquid solution and each environmentally-gated transistor includes a drain, a source, and a Carbon-based substrate channel, the drain electrically couples to a first location on the substrate channel, the source electrically couples to a second location on the substrate channel separated by a gap from the first location on the substrate channel, the environmental gate covers and contacts the substrate channel, a first insulating layer covers and separates the drain from the environmental gate, and a second insulating layer covers and separates the source from the environmental gate.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: August 17, 2021
    Assignee: Cardea Bio, Inc.
    Inventor: Brett Goldsmith
  • Patent number: 11056343
    Abstract: Embodiments of the disclosed technology include patterning a graphene sheet for biosensor and electronic applications using lithographic patterning techniques. More specifically, the present disclosure is directed towards the method of patterning a graphene sheet with a hard mask metal layer. The hard mask metal layer may include an inert metal, which may protect the graphene sheet from being contaminated or damaged during the patterning process.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: July 6, 2021
    Assignee: Cardea Bio, Inc.
    Inventors: Deng Pan, Brett Goldsmith
  • Publication number: 20210041429
    Abstract: Apparatuses, systems, and methods are disclosed for transportation and detection of analytes. Beads may be functionalized with a capture moiety to bind to a target moiety. Beads that have not been incubated in a sample solution may be positioned in a fluid, near a sensing surface for a biosensor. A calibration measurement may be performed using the biosensor, after which the beads may be removed. Beads that have been incubated in the sample solution may be positioned near the sensing surface, and a detection measurement may be performed using the biosensor. A parameter such as the presence, absence or concentration of the target moiety in the sample solution may be determined based on the calibration measurement and the detection measurement.
    Type: Application
    Filed: August 7, 2020
    Publication date: February 11, 2021
    Inventors: Regis Paytavi, Kiana Aran, Brett Goldsmith, Alexander Kane
  • Patent number: 10903319
    Abstract: Embodiments of the disclosed technology include patterning a graphene sheet for biosensor and electronic applications using lithographic patterning techniques. More specifically, the present disclosure is directed towards the method of patterning a graphene sheet with a hard mask metal layer. The hard mask metal layer may include an inert metal, which may protect the graphene sheet from being contaminated or damaged during the patterning process.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 26, 2021
    Assignee: Nanomedical Diagnostics, Inc.
    Inventors: Deng Pan, Brett Goldsmith
  • Publication number: 20200326300
    Abstract: Apparatuses, systems, and methods are disclosed for target detection based on collateral cleavage of a reporter by an enzyme. A biologically gated transistor may include a channel and a reporter moiety immobilized to the channel. The state of the reporter moiety may affect one or more output signals from the biologically gated transistor when excitation conditions are applied to the biologically gated transistor and a sample fluid is applied in contact with the channel. A sample fluid may include an enzyme configured to activate in response to a target nucleic acid to cleave the reporter moiety. Excitation circuitry may apply the excitation conditions, and measurement circuitry may measure output signals from the biologically gated transistor. An analysis module may determine a parameter relating to presence of the target nucleic acid, based on the one or more measurements.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 15, 2020
    Inventors: Kiana Aran, Alexander Kane, Brett Goldsmith, Regis Paytavi
  • Patent number: 10759157
    Abstract: The present disclosure is directed towards systems and methods for transferring graphene from the surface of one substrate to another. In one particular embodiment, the graphene layer is grown on a surface of a first substrate, where the bottom of the first substrate is then affixed to the surface of a second substrate. The second substrate may include material made of a rigid or semi-rigid composition to provide structural support and backing to the first substrate. The graphene layer may then be delaminated from the first substrate and transferred to a target surface, such as the surface of an electronic device or biosensor.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: September 1, 2020
    Assignee: Nanomedical Diagnostics, Inc.
    Inventors: Mitchell Lerner, Deng Pan, Brett Goldsmith, Savannah J. Afsahi
  • Patent number: 10751986
    Abstract: The present disclosure is directed towards systems for transferring graphene from the surface of one substrate to another. In one particular embodiment, the graphene layer is grown on a surface of a first substrate, where the bottom of the first substrate is then affixed to the surface of a second substrate. The second substrate may include material made of a rigid or semi-rigid composition to provide structural support and backing to the first substrate. The graphene layer may then be delaminated from the first substrate and transferred to a target surface, such as the surface of an electronic device or biosensor.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: August 25, 2020
    Assignee: Nanomedical Diagnostics, Inc.
    Inventors: Mitchell Lerner, Deng Pan, Brett Goldsmith, Savannah J. Afsahi
  • Publication number: 20200248173
    Abstract: For enhanced selection of efficient targeted genome manipulating agents, an apparatus includes first and second chip-based biosensors having one or more sensing surfaces configured to detect biomolecular binding interactions between a nucleic acid sample and a targeted genome manipulating agent functionalized to a capture surface within a sensing range of the one or more sensing surfaces. The first chip-based biosensor uses a nucleic acid sample incubated with a blocking agent that blocks on-target binding and the second chip-based biosensor holds a nucleic acid sample that omits the blocking agent. A measurement apparatus measures first and second sets of response signals produced in response to the biomolecular binding interactions occurring between the nucleic acid sample and the targeted genome manipulating agent. An analysis module determines the genome manipulating efficiency parameters of the targeted genome manipulating agent. A system and a method perform the functions of the apparatus.
    Type: Application
    Filed: February 5, 2020
    Publication date: August 6, 2020
    Inventors: Regis Paytavi, Kiana Aran, Brett Goldsmith, Alexander Kane
  • Publication number: 20190351665
    Abstract: The present disclosure is directed towards systems for transferring graphene from the surface of one substrate to another. In one particular embodiment, the graphene layer is grown on a surface of a first substrate, where the bottom of the first substrate is then affixed to the surface of a second substrate. The second substrate may include material made of a rigid or semi-rigid composition to provide structural support and backing to the first substrate. The graphene layer may then be delaminated from the first substrate and transferred to a target surface, such as the surface of an electronic device or biosensor.
    Type: Application
    Filed: July 25, 2019
    Publication date: November 21, 2019
    Applicant: Nanomedical Diagnostics, Inc.
    Inventors: Mitchell Lerner, Deng Pan, Brett Goldsmith, Savannah J. Afsahi
  • Patent number: 10395928
    Abstract: Embodiments of the disclosed technology include depositing a passivation layer onto a surface of a wafer that may include a graphene layer. The passivation layer may protect and isolate the graphene layer from electrical and chemical conditions that may damage the graphene layer. As such, the passivation layer may further protect the graphene sensor from being damaged and impaired for its intended use. Additionally, the passivation layer may be patterned to expose select areas of the graphene layer below the passivation layer, thus creating graphene wells and exposing the graphene layer to the appropriate chemicals and solutions.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: August 27, 2019
    Assignee: Nanomedical Diagnostics, Inc.
    Inventors: Deng Pan, Brett Goldsmith, Mitchell Lerner
  • Publication number: 20180037952
    Abstract: A DNA sequencing and blood chemistry analysis system and method are provided including one or more sensor chips and one or more sample wells, wherein each sample well is configured to form a seal with one of the sensors. The one or more sensor chips may comprise Graphene transistors, and each transistor having an associated sequencing probe. The sensor chips interact with a biological sample introduced into the sample well, wherein changes in the current, transconductance, and resistance of the Graphene transistors are indicative of a DNA binding process. Based on the associated sequencing probes, the DNA sequence present in a biological sample can be identified.
    Type: Application
    Filed: August 21, 2017
    Publication date: February 8, 2018
    Applicant: Nanomedical Diagnostics, Inc.
    Inventor: Brett GOLDSMITH
  • Publication number: 20170365562
    Abstract: Embodiments of the disclosed technology include patterning a graphene sheet for biosensor and electronic applications using lithographic patterning techniques. More specifically, the present disclosure is directed towards the method of patterning a graphene sheet with a hard mask metal layer. The hard mask metal layer may include an inert metal, which may protect the graphene sheet from being contaminated or damaged during the patterning process.
    Type: Application
    Filed: June 14, 2017
    Publication date: December 21, 2017
    Applicant: Nanomedical Diagnostics, Inc.
    Inventors: DENG PAN, BRETT GOLDSMITH